首页> 外文学位 >Novel approaches for the diagnosis of protein -losing enteropathy and small -intestinal bacterial overgrowth in dogs.
【24h】

Novel approaches for the diagnosis of protein -losing enteropathy and small -intestinal bacterial overgrowth in dogs.

机译:诊断犬蛋白丢失性肠病和小肠细菌过度生长的新方法。

获取原文
获取原文并翻译 | 示例

摘要

Protein-losing enteropathy (PLE) is a term that encompasses a heterogeneous group of diseases in which plasma proteins are lost into the gastrointestinal tract. PLE has been documented in association with more than 50 GI disorders in human beings. The classical gold standard for diagnosis of PLE is to quantitate loss of radioactive (51Cr-labeled) albumin into the gastrointestinal tract. This test has not been widely used clinically because it requires a minimum-five day fecal and urine collection in approved facilities and exposes the patient and operator to certain degree of radiation. Fecal alpha1-protease inhibitor (falpha1- PI) assay has been shown to be a reliable alternative method to detect PLE in human beings. Small Intestinal Bacterial Overgrowth (SIBO) is another important complication of spontaneous gastrointestinal diseases in dogs. As in human patients, the gold standard for the diagnosis of bacterial overgrowth in dogs is quantitative anaerobic and aerobic culture of small bowel aspirates. This diagnostic method is technically difficult, expensive and impractical for use on a routine basis. Previous reports have suggested the use of serum unconjugated bile acids as a test for SIBO in human beings as a more practical diagnostic technique. At present there is no practical test for PLE and SIBO in dogs. Thus, this investigation was undertaken to study novel approaches for the diagnosis of these two gastrointestinal disorders in dogs. The results of this investigation revealed that assay of fecal alpha1-PI is promising disease marker for protein-losing enteropathy states in dogs. These observations were substantiated when our results were compared with the classical gold standard (51Cr-labeled albumin) for the diagnosis of PLE. Likewise, Serum Unconjugated Bile Acid (SUBA) concentrations increased 10--20 fold in dogs with SIBO when compared to normal dogs indicating the clinical utility of SUBA for the diagnosis of SIBO in dogs. Availability of these two novel diagnostic assays will facilitate further characterization and better understanding of these canine disorders and may well uncover causes of PLE and SIBO in this species that are not yet suspected.
机译:蛋白质丢失性肠病(PLE)是一个术语,涵盖了一组异质性疾病,其中血浆蛋白丢失到胃肠道中。 PLE已被证明与人类50多种胃肠道疾病有关。诊断PLE的经典金标准是量化放射性(51Cr标记)白蛋白向胃肠道的损失。该测试尚未在临床上得到广泛应用,因为它需要在认可的设施中收集至少五天的粪便和尿液,并使患者和操作者受到一定程度的辐射。粪便α1-蛋白酶抑制剂(falpha1-PI)分析已被证明是检测人类PLE的可靠替代方法。小肠细菌过度生长(SIBO)是犬自发性胃肠道疾病的另一个重要并发症。与人类患者一样,诊断狗细菌过度生长的金标准是小肠抽吸物的定量厌氧和需氧培养。这种诊断方法在技术上是困难的,昂贵的并且不能常规使用。先前的报道建议使用血清未结合的胆汁酸作为对人中SIBO的测试,作为一种更实用的诊断技术。目前尚无针对狗的PLE和SIBO的实际测试。因此,进行了这项研究以研究诊断犬中这两种胃肠道疾病的新颖方法。这项研究的结果表明,粪便中α1-PI的测定是狗中蛋白质丢失性肠病状态的有前途的疾病标记。将我们的结果与经典金标准(51Cr标记的白蛋白)进行PLE诊断相比,这些观察结果得到了证实。同样,与正常犬相比,患有SIBO的犬的血清未结合胆汁酸(SUBA)浓度增加了10--20倍,表明SUBA在犬中诊断SIBO的临床效用。这两种新颖的诊断检测方法的可用性将有助于进一步鉴定和更好地了解这些犬类疾病,并可能很好地发现尚未怀疑的该物种中PLE和SIBO的原因。

著录项

  • 作者单位

    Purdue University.;

  • 授予单位 Purdue University.;
  • 学科 Veterinary science.;Biochemistry.
  • 学位 Ph.D.
  • 年度 1999
  • 页码 105 p.
  • 总页数 105
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号